Interferon antagonists encoded by SARS-CoV-2 at a glance

JH Lee, L Koepke, F Kirchhoff, KMJ Sparrer - Medical microbiology and …, 2023 - Springer
… However, successful viruses like SARS-CoV-2 have evolved strategies to evade or counteract
… overview of how SARS-CoV-2 uses many of its proteins to counteract IFN induction and …

SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists

CK Yuen, JY Lam, WM Wong, LF Mak… - Emerging microbes & …, 2020 - Taylor & Francis
… the key viral interferon antagonists of SARS-CoV-2 and … SARS-CoV-2 interferon antagonists
identified in this study are highlighted orange, with PLpro that has compromised interferon

[PDF][PDF] SARS-CoV-2 is sensitive to type I interferon pretreatment

KG Lokugamage, A Hage, C Schindewolf, R Rajsbaum… - BioRxiv, 2020 - scienceopen.com
… between SARS-CoV and SARS-CoV-2 in 15 viral proteins shown to be interferon antagonist.
… to ORF6 suggest the two key IFN antagonists may not maintain 17 equivalent function in …

[HTML][HTML] SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant

Y Konno, I Kimura, K Uriu, M Fukushi, T Irie… - Cell reports, 2020 - cell.com
… Because the ORF3b length is remarkably different between SARS-CoV-2 and SARS-CoV
(Figure 1B), we hypothesized that the antagonistic activity of ORF3b against IFN-I also differs …

[HTML][HTML] Immune evasion of SARS-CoV-2 from interferon antiviral system

YQ Min, M Huang, X Sun, F Deng, H Wang… - Computational and …, 2021 - Elsevier
IFN antagonistic proteins summarized in this review. Identification of natural SARS-CoV-2
variants with the potential IFN antagonists mutated also could be valuable to assess the IFN-…

Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics

S Schroeder, F Pott, D Niemeyer, T Veith… - The Lancet …, 2021 - thelancet.com
… To evaluate the antagonistic function of SARS-CoV-2 protein 6 in interferon signalling,
we did single-cycle infection experiments (MOI of 1) in Vero E6 cells. We allowed for 16 h of …

Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV

KG Lokugamage, A Hage, M de Vries… - Journal of …, 2020 - Am Soc Microbiol
… Comparing SARS-CoV-2 and influenza A virus in human … observe the absence of IFN-I
stimulation by SARS-CoV-2 alone … of IFN-I antagonist proteins encoded by SARS-CoV-2, SARS-…

SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon

AL Totura, RS Baric - Current opinion in virology, 2012 - Elsevier
IFN antagonist proteins within the SARS-CoV genome [80, 83]. Structural components of the
SARS-CoV virion acting as antagonists of IFN … antagonism of IFN signaling by SARS-CoV is …

Activation and evasion of type I interferon responses by SARS-CoV-2

X Lei, X Dong, R Ma, W Wang, X Xiao, Z Tian… - Nature …, 2020 - nature.com
SARS-CoV-2 induces overt but delayed type-I interferon (IFN) responses. By screening 23
viral proteins, we find that SARS-CoV-… of SARS-CoV ORF6 is critical for its antagonistic activity …

The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway

JY Li, CH Liao, Q Wang, YJ Tan, R Luo, Y Qiu, XY Ge - Virus research, 2020 - Elsevier
… -2 ORF6, ORF8, N and ORF3b are potent interferon antagonist, in the early stages of
SARS-CoV-2 infection, delayed release of IFNs would hinder the host's antiviral response and then …